E-hospital: Fully coordinated cancer care and research in Europe

ESMO Highlights: Breast cancer

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Cancer care in developing countries

PD-L1 protein a possible immunotherapy target in mesothelioma

The evolving treatment landscape for HER2-positive metastatic breast cancer

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Global prostate cancer disparities and the parts both genetic and behavioural factors play

Looking for biomarkers in metronomic chemotherapy

Metronomics and low/middle income countries, especially in breast cancer

New metronomic approach to neuroblastoma

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care